Endosome (early 3)

[{"image":"https://icons.cdn.biorender.com/w75xh75/5bf5a07e23b59f1200cf22cb/5bf459fd60a7c41200c5ee6a.png","waterMarkImage":"https://icons.cdn.biorender.com/w550xh620/5bf5a07e23b59f1200cf22cb/5bf459fd60a7c41200c5ee6a.png"},{"image":"https://icons.cdn.biorender.com/w75xh75/5bf5a07e23b59f1200cf22ca/5bf459fd60a7c41200c5ee6a.png","waterMarkImage":"https://icons.cdn.biorender.com/w550xh620/5bf5a07e23b59f1200cf22ca/5bf459fd60a7c41200c5ee6a.png"},{"image":"https://icons.cdn.biorender.com/w75xh75/5bf5a07e23b59f1200cf22c9/5bf459fd60a7c41200c5ee6a.png","waterMarkImage":"https://icons.cdn.biorender.com/w550xh620/5bf5a07e23b59f1200cf22c9/5bf459fd60a7c41200c5ee6a.png"},{"image":"https://icons.cdn.biorender.com/w75xh75/5bf5a07e23b59f1200cf22c8/5bf459fd60a7c41200c5ee6a.png","waterMarkImage":"https://icons.cdn.biorender.com/w550xh620/5bf5a07e23b59f1200cf22c8/5bf459fd60a7c41200c5ee6a.png"},{"image":"https://icons.cdn.biorender.com/w75xh75/5bf5a07e23b59f1200cf22c7/5bf459fd60a7c41200c5ee6a.png","waterMarkImage":"https://icons.cdn.biorender.com/w550xh620/5bf5a07e23b59f1200cf22c7/5bf459fd60a7c41200c5ee6a.png"},{"image":"https://icons.cdn.biorender.com/w75xh75/5bf5a07e23b59f1200cf22c6/5bf459fd60a7c41200c5ee6a.png","waterMarkImage":"https://icons.cdn.biorender.com/w550xh620/5bf5a07e23b59f1200cf22c6/5bf459fd60a7c41200c5ee6a.png"},{"image":"https://icons.cdn.biorender.com/w75xh75/5bf5a07e23b59f1200cf22c5/5bf459fd60a7c41200c5ee6a.png","waterMarkImage":"https://icons.cdn.biorender.com/w550xh620/5bf5a07e23b59f1200cf22c5/5bf459fd60a7c41200c5ee6a.png"},{"image":"https://icons.cdn.biorender.com/w75xh75/5bf5a07e23b59f1200cf22c4/5bf459fd60a7c41200c5ee6a.png","waterMarkImage":"https://icons.cdn.biorender.com/w550xh620/5bf5a07e23b59f1200cf22c4/5bf459fd60a7c41200c5ee6a.png"},{"image":"https://icons.cdn.biorender.com/w75xh75/5bf5a07e23b59f1200cf22c3/5bf459fd60a7c41200c5ee6a.png","waterMarkImage":"https://icons.cdn.biorender.com/w550xh620/5bf5a07e23b59f1200cf22c3/5bf459fd60a7c41200c5ee6a.png"},{"image":"https://icons.cdn.biorender.com/w75xh75/5bf5a07e23b59f1200cf22c2/5bf459fd60a7c41200c5ee6a.png","waterMarkImage":"https://icons.cdn.biorender.com/w550xh620/5bf5a07e23b59f1200cf22c2/5bf459fd60a7c41200c5ee6a.png"},{"image":"https://icons.cdn.biorender.com/w75xh75/5bf5a07e23b59f1200cf22c1/5bf459fd60a7c41200c5ee6a.png","waterMarkImage":"https://icons.cdn.biorender.com/w550xh620/5bf5a07e23b59f1200cf22c1/5bf459fd60a7c41200c5ee6a.png"},{"image":"https://icons.cdn.biorender.com/w75xh75/5bf5a07e23b59f1200cf22c0/5bf459fd60a7c41200c5ee6a.png","waterMarkImage":"https://icons.cdn.biorender.com/w550xh620/5bf5a07e23b59f1200cf22c0/5bf459fd60a7c41200c5ee6a.png"},{"image":"https://icons.cdn.biorender.com/w75xh75/5bf5a07e23b59f1200cf22bf/5bf459fd60a7c41200c5ee6a.png","waterMarkImage":"https://icons.cdn.biorender.com/w550xh620/5bf5a07e23b59f1200cf22bf/5bf459fd60a7c41200c5ee6a.png"},{"image":"https://icons.cdn.biorender.com/w75xh75/5bf5a07e23b59f1200cf22be/5bf459fd60a7c41200c5ee6a.png","waterMarkImage":"https://icons.cdn.biorender.com/w550xh620/5bf5a07e23b59f1200cf22be/5bf459fd60a7c41200c5ee6a.png"},{"image":"https://icons.cdn.biorender.com/w75xh75/5bf5a07e23b59f1200cf22bd/5bf459fd60a7c41200c5ee6a.png","waterMarkImage":"https://icons.cdn.biorender.com/w550xh620/5bf5a07e23b59f1200cf22bd/5bf459fd60a7c41200c5ee6a.png"}]